Abstract
In a large, open-label study of 522 patients diagnosed as essential hypertensives, atenolol was both effective and well tolerated. In 392 patients whose blood pressure was measured at the initial visit and after at least four weeks of atenolol therapy, average reductions of 21 mm Hg and 14 mm Hg, were noted in the systolic and diastolic blood pressure respectively. Forty-three patients stopped taking atenolol because of side-effects. The incidence of CNS side-effects was particularly low, and the drug was well tolerated by diabetic patients. Among eight asthmatics who took atenolol, asthma worsened in two. By virtue of its hydrophilicity, cardioselectivity and long half-life, atenolol appears to be a suitable and well-tolerated beta-blocker in the majority of patients.
Keywords: hypertension, atenolol, drug therapy
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bühler F. R., Burkart F., Lütold B. E., Küng M., Marbet G., Pfisterer M. Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Am J Cardiol. 1975 Oct 31;36(5):653–669. doi: 10.1016/0002-9149(75)90168-x. [DOI] [PubMed] [Google Scholar]
- Lauridsen U. B., Christensen N. J., Lyngsøe J. Effects of nonselective and beta-1-selective blockade on glucose metabolism and hormone responses during insulin-induced hypoglycemia in normal man. J Clin Endocrinol Metab. 1983 May;56(5):876–882. doi: 10.1210/jcem-56-5-876. [DOI] [PubMed] [Google Scholar]
- Lawrence D. S., Sahay J. N., Chatterjee S. S., Cruickshank J. M. Asthma and beta-blockers. Eur J Clin Pharmacol. 1982;22(6):501–509. doi: 10.1007/BF00609622. [DOI] [PubMed] [Google Scholar]
- McDevitt D. G. Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant? Drugs. 1983 Apr;25(4):331–338. doi: 10.2165/00003495-198325040-00001. [DOI] [PubMed] [Google Scholar]